Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRADLE: Preoperative CCRT for GEJ Adenocarcinoma
NCT02193594Phase 3Unknown
- Sponsor
- Peking University
- Start
- Jan 2014
- Primary completion
- Sep 2017
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of oxaliplatin, tegafur in gastroesophageal junction adenocarcinoma, gastric adenocarcinoma, sponsored by Peking University. Status: unknown.
02
Drugs
oxaliplatintegafur
03
Conditions
gastroesophageal junction adenocarcinomagastric adenocarcinoma
Beyond the preview
Go deeper on NCT02193594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02193594.